Abstract:Background: Trichothiodystrophy-1 (TTD1) is an autosomal-recessive disease and caused by mutations in ERCC2, a gene coding for a subunit of the TFIIH transcription and nucleotide-excision repair (NER) factor. In almost half of these patients infectious susceptibility has been reported but the underlying molecular mechanism leading to immunodeficiency is largely unknown. Objective: The aim of this study was to perform extended molecular and immunological phenotyping in patients suffering from TTD1. Methods: Cellular immune phenotype was investigated using multicolor flow cytometry. DNA repair efficiency was evaluated in UV-irradiation assays. Furthermore, early BCR activation events and proliferation of TTD1 lymphocytes following DNA damage induction was tested. In addition, we performed differential gene expression analysis in peripheral lymphocytes of TTD1 patients. Results: We investigated three unrelated TTD1 patients who presented with recurrent infections early in life of whom two harbored novel ERCC2 mutations and the third patient is a carrier of previously described pathogenic ERCC2 mutations. Hypogammaglobulinemia and decreased antibody responses following vaccination were found. TTD1 B-cells showed accumulation of γ-H2AX levels, decreased proliferation activity and reduced cell viability following UV-irradiation. mRNA sequencing analysis revealed significantly downregulated genes needed for B-cell development and activation. Analysis of B-cell subpopulations showed low numbers of naïve and transitional B-cells in TTD1 patients, indicating abnormal B-cell differentiation in vivo. Conclusion: In summary, our analyses confirmed the pathogenicity of novel ERCC2 mutations and show that ERCC2 deficiency is associated with antibody deficiency most likely due to altered B-cell differentiation resulting from impaired BCR-mediated B-cell activation and activation-induced gene transcription.

Independent mutations of the human CD3–ε gene resulting in a T cell receptor/CD3 complex immunodeficiency

[THE DEVELOPMENT OF THE ATOPIC SYNDROME IN A GROUP OF PATIENTS WITH CONSTITUTIONAL ECZEMA].

NUDCD3 deficiency disrupts V(D)J recombination to cause SCID and Omenn syndrome

Structure of the T-cell antigen receptor: evidence for two CD3 epsilon subunits in the T-cell receptor-CD3 complex.

In Vitro Translation and Assembly of a Complete T Cell Receptor–CD3 Complex

Study for complementarity determining region 3 of T cell receptor beta chain in infectious diseases

A human ITPR3 variant causes a dominant negative attenuation of calcium responses with immunodeficiency and growth delay confirmed in a mouse model

Structure of an interferon-alpha 2 gene expressed in the bovine conceptus early in gestation.

Dual T Cell– and B Cell–intrinsic Deficiency in Humans with Biallelic RLTPR Mutations

[Honeybee venom. II. Amino acid composition of bee venom fractions].

Impaired B-cell function in ERCC2 deficiency

Cutting Edge: TCR- Selection Is Required at the CD4<SUP>+</SUP>CD8<SUP>+</SUP> Stage of Human T Cell Development

Case Report: Novel Splicing Mutations in RFX5 Causing MHC Class II Deficiency

Effects of B16 melanoma transplantation on the respiration of grouped C57Bl female mice.

A CD3G homozygous pathogenic variant in a Chinese child with lupus-like disease, autoimmune thyroiditis and immunodeficiency

A pleiotropic recurrent dominant ITPR3 variant causes a complex multisystemic disease

[Human immunoglobulins].

Novel IL2RG Gene Mutation in One of Dizygotic Twins Causing Profound Changes of Receptor Structure

Exploitation of CD3ζ to enhance TCR expression levels and antigen-specific T cell function

Human interleukin-2 receptor β mutations associated with defects in immunity and peripheral tolerance

Enhanced retention of cytosine arabinoside and its metabolites and synergistic cytotoxicity by sequential treatment with dipyridamole in L5178Y leukemia